Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Oroville Hospital located at 2767 Olive Hwy, Oroville, CA, 95966 & includes data from NPIs 1871606269, 1679581557
Dexur analyzed Q3 2018 (July to September 2018) Medicare claims data to benchmark length of stay (LOS) outcomes for Oroville Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,535 | 1,403 | ||||||||||
| Surgical | 191 | 180 | ||||||||||
| Non Surgical | 1,344 | 1,223 | ||||||||||
| General Medicine | 526 | 483 | ||||||||||
| Cardiovascular | 276 | 231 | ||||||||||
| Gastroenterology & Endocrinology | 147 | 137 | ||||||||||
| Urology | 128 | 127 | ||||||||||
| Neurology | 113 | 98 | ||||||||||
| Orthopedics | 113 | 109 | ||||||||||
| Pulmonology | 80 | 78 | ||||||||||
| General Surgery | 72 | 63 | ||||||||||
| Oncology & Hematology | 25 | 25 | ||||||||||
| Psychiatry & Mental Disorders | 18 | 18 | ||||||||||
| Obstetrics & Gynecology | 16 | 14 | ||||||||||
| Colorectal | 11 | 11 |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Injury, Poisoning And Toxic Effect Diagnoses |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Hypertension | ||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| G.I. Obstruction |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Urinary Stones | ||||||||||||
| Kidney And Urinary Tract Infections |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| Seizures | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Respiratory System Diagnoses |
| Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | California Total Hospitalizations (Jul 2018 to Sep 2018) | California Total Hospitalizations After Exclusion | California Total Users | California Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |